Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,495 | -38,422 | -17,710 | -62,222 | -46,034 |
| Depreciation Amortization | 44 | 32 | 20 | 114 | 88 |
| Income taxes - deferred | 0 | N/A | N/A | -70 | N/A |
| Accounts payable and accrued liabilities | 134 | 1,935 | 2,356 | -1,463 | -1,453 |
| Other Working Capital | 266 | 1,203 | 343 | 3,259 | 2,790 |
| Other Operating Activity | 18,118 | 12,840 | 3,325 | 16,956 | 15,128 |
| Operating Cash Flow | $-34,933 | $-22,412 | $-11,666 | $-43,426 | $-29,481 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,368 | 12,904 | 5,305 | 24,019 | 21,240 |
| PPE Investments | -50 | -50 | N/A | -25 | -25 |
| Investing Cash Flow | $23,318 | $12,854 | $5,305 | $23,994 | $21,215 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,728 | 29,594 | 27,782 | 3,889 | 1,187 |
| Financing Cash Flow | $31,728 | $29,594 | $27,782 | $3,889 | $1,187 |
| Beginning Cash Position | 4,316 | 4,316 | 4,316 | 19,859 | 19,859 |
| End Cash Position | 24,429 | 24,352 | 25,737 | 4,316 | 12,780 |
| Net Cash Flow | $20,113 | $20,036 | $21,421 | $-15,543 | $-7,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,933 | -22,412 | -11,666 | -43,426 | -29,481 |
| Capital Expenditure | -50 | -50 | N/A | -25 | -25 |
| Free Cash Flow | -34,983 | -22,462 | -11,666 | -43,451 | -29,506 |